ConcertAI’s TeraRecon Enhances its Eureka Clinical AI Platform with AI-Based Prostate Cancer Diagnostic Solutions from Lucida Medical
CAMBRIDGE, Mass., Nov. 15, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, today announced the addition of Lucida Medical to its Eureka Clinical AI Platform ecosystem. It will be deployed within the UK’s National Health Service (NHS) and European healthcare systems. Pi™ (Prostate Intelligence™), Lucida Medical’s AI-machine…